India's Lupin says FDA raises concerns over plant at Pithampur

MUMBAI (Reuters) - The U.S. Food and Drug Administration (FDA) has raised concerns over production processes at a plant that makes oral contraceptives operated by Lupin Ltd, India's fourth-largest generic drug manufacturer by sales.